{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:14:48Z","timestamp":1758820488538,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007429","name":"Nancy Lurie Marks Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10803-021-05254-8","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T19:24:50Z","timestamp":1631215490000},"page":"4164-4171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder"],"prefix":"10.1007","volume":"52","author":[{"given":"Majd","family":"Al-Soleiti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Balaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn P.","family":"Thom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6229-9293","authenticated-orcid":false,"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Keary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"5254_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.","edition":"5"},{"issue":"3","key":"5254_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","volume":"49","author":"A Aran","year":"2019","unstructured":"Aran, A., Cassuto, H., Lubotzky, A., Wattad, N., & Hazan, E. (2019). Brief report: Cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems\u2014A retrospective feasibility study. Journal of Autism and Developmental Disorders, 49(3), 1284\u20131288.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"5254_CR3","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3389\/fphar.2018.01521","volume":"9","author":"D Barchel","year":"2019","unstructured":"Barchel, D., Stolar, O., De-Haan, T., Ziv-Baran, T., Saban, N., Fuchs, D. O., Koren, G., & Berkovitch, M. (2019). Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. Frontiers in Pharmacology, 9, 1521. https:\/\/doi.org\/10.3389\/fphar.2018.01521 (eCollection 2018).","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"5254_CR4","first-page":"180","volume":"42","author":"MB Bridgeman","year":"2017","unstructured":"Bridgeman, M. B., & Abazia, D. T. (2017). Medicinal cannabis: History, pharmacology, and implications for the acute care setting. Pharmacy and Therapeutics, 42(3), 180\u2013188.","journal-title":"Pharmacy and Therapeutics"},{"issue":"7","key":"5254_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2019.11.020","volume":"179","author":"Cross-Disorder Group of the Psychiatric Genomics Consortium","year":"2019","unstructured":"Cross-Disorder Group of the Psychiatric Genomics Consortium. (2019). Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell, 179(7), 1469\u20131482.","journal-title":"Cell"},{"issue":"21","key":"5254_CR6","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky, O., Cross, J. H., Laux, L., March, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., Wright, S., & Cannabidiol in Dravet Syndrome Study Group. (2017). Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine, 376(21), 2011\u20132020.","journal-title":"New England Journal of Medicine"},{"key":"5254_CR7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0558","author":"SW Duvall","year":"2019","unstructured":"Duvall, S. W., Lindly, O., Zuckerman, K., Msall, M. E., & Weddle, M. (2019). Ethical implications for providers regarding cannabis use in children with autism spectrum disorders. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2018-0558","journal-title":"Pediatrics"},{"issue":"5","key":"5254_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/jamapsychiatry.2020.3564","volume":"78","author":"NA Gillespie","year":"2021","unstructured":"Gillespie, N. A., & Kendler, K. S. (2021). Use of genetically informed methods to clarify the nature of the association between cannabis use and risk for schizophrenia. JAMA Psychiatry, 78(5), 467\u2013468.","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"5254_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/jamapsychiatry.2016.0251","volume":"73","author":"FS Goes","year":"2016","unstructured":"Goes, F. S., Pirooznia, M., Parla, J. S., Kramer, M., Ghiban, E., Mavruk, S., Chen, Y.-C., Monson, E. T., Willour, V. L., Karchin, R., Flickinger, M., Locke, A. E., Levy, S. E., Scott, L. J., Boehnke, M., Stahl, E., Moran, J. L., Hultman, C. M., Landen, M., \u2026 Potash, J. B. (2016). Exome sequencing of familial bipolar disorder. JAMA Psychiatry, 73(6), 590\u2013597.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"5254_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41398-018-0155-1","volume":"8","author":"J Horder","year":"2018","unstructured":"Horder, J., Petrinovic, M. M., Mendez, M. A., Bruns, A., Takumi, T., Spooren, W., Barker, G. J., Kunnecke, B., & Murphy, D. G. (2018). Glutamate and GABA in autism spectrum disorder\u2014A translational magnetic resonance spectroscopy study in man and rodent models. Translational Psychiatry, 8(1), 106.","journal-title":"Translational Psychiatry"},{"key":"5254_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2174\/1570159X17666190603171901","volume":"17","author":"MA Huestis","year":"2019","unstructured":"Huestis, M. A., Solimini, R., Pichini, R., Carlier, J., & Busardo, F. P. (2019). Cannabidiol adverse effects and toxicity. Current Neuropharmacology, 17, 974\u2013989.","journal-title":"Current Neuropharmacology"},{"issue":"1\u20133","key":"5254_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","volume":"162","author":"TA Iseger","year":"2015","unstructured":"Iseger, T. A., & Bossong, M. G. (2015). A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophrenia Research, 162(1\u20133), 153\u2013161.","journal-title":"Schizophrenia Research"},{"issue":"3","key":"5254_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamapsychiatry.2017.4271","volume":"75","author":"HJ Jones","year":"2018","unstructured":"Jones, H. J., Gage, S. H., Heron, J., Hickman, M., Lewis, G., Munaf\u00f2, M. R., & Zammit, S. (2018). Association of combined patterns of tobacco and cannabis use in adolescence with psychotic experiences. JAMA Psychiatry, 75(3), 240\u2013246.","journal-title":"JAMA Psychiatry"},{"key":"5254_CR14","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jns.2017.08.2623","volume":"381","author":"G Kuester","year":"2017","unstructured":"Kuester, G., Vergara, K., Ahumada, A., & Gazmuri, A. M. (2017). Oral cannabis extracts as a promising treatment for the core symptoms of autism spectrum disorder: Preliminary experience in chilean patients. Journal of the Neurological Sciences, 381, 932\u2013933.","journal-title":"Journal of the Neurological Sciences"},{"key":"5254_CR15","first-page":"4","volume":"5","author":"R Kurz","year":"2010","unstructured":"Kurz, R., & Blaas, K. (2010). Use of dronabinol (delta-9-THC) in autism: A prospective single-case study with an early infantile autistic child. Cannabinoids, 5, 4\u20136.","journal-title":"Cannabinoids"},{"issue":"4","key":"5254_CR16","first-page":"12","volume":"50","author":"Y Lee","year":"2018","unstructured":"Lee, Y., Zhang, Y., Kim, S., & Han, K. (2018). Excitatory and inhibitory synaptic dysfunction in mania: An emerging hypothesis from animal model studies. Experimental & Molecular Medicine, 50(4), 12.","journal-title":"Experimental & Molecular Medicine"},{"issue":"12","key":"5254_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015). The endocannabinoid system in guarding against fear, anxiety and stress. Nature Reviews Neuroscience, 16(12), 705\u2013718.","journal-title":"Nature Reviews Neuroscience"},{"key":"5254_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"SA Millar","year":"2018","unstructured":"Millar, S. A., Stone, N. L., Yates, A. S., & O\u2019Sullivan, S. E. (2018). A systematic review on the pharmacokinetics of cannabidiol in humans. Frontiers in Pharmacology, 9, 1365. https:\/\/doi.org\/10.3389\/fphar.2018.01365","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"5254_CR19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10803-014-2307-3","volume":"45","author":"NF Minshawi","year":"2015","unstructured":"Minshawi, N. F., Hurwitz, S., Morriss, D., & McDougle, C. J. (2015). Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: Integration of psychological and biological theory and approach. Journal of Autism and Developmental Disorders, 45(6), 1541\u20131568.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"5254_CR20","doi-asserted-by":"publisher","first-page":"100833","DOI":"10.1016\/j.spen.2020.100833","volume":"35","author":"M Mostafavi","year":"2020","unstructured":"Mostafavi, M., & Gaitanis, J. (2020). Autism spectrum disorder and medical cannabis: Review and clinical experience. Seminars in Pediatric Neurology, 35, 100833.","journal-title":"Seminars in Pediatric Neurology"},{"key":"5254_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pnpbp.2018.08.030","volume":"89","author":"S Poleg","year":"2019","unstructured":"Poleg, S., Golubchik, P., Offen, D., & Weizman, A. (2019). Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 89, 90\u201396.","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"5254_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00213-013-3068-y","volume":"231","author":"LC Politte","year":"2014","unstructured":"Politte, L. C., & McDougle, C. J. (2014). Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl), 231, 1023\u20131036.","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"5254_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41386-019-0333-8","volume":"44","author":"CM Pretzsch","year":"2019","unstructured":"Pretzsch, C. M., Freyberg, J., Voinescu, B., Lythgoe, D., Horder, J., Mendez, M. A., Wichers, R., Ajram, L., Ivin, G., Heasman, M., Edden, R. A. E., Williams, S., Murphy, D. G. M., Daly, E., & McAlonan, G. M. (2019). Effects of cannabidiol on brain excitation and inhibition systems: A randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. Neuropsychopharmacology, 44(8), 1398\u20131405.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"5254_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/cpt.421","volume":"101","author":"RA Rabin","year":"2017","unstructured":"Rabin, R. A., & George, T. P. (2017). Understanding the link between cannabinoids and psychosis. Clinical Pharmacology & Therapeutics, 101(2), 197\u2013199.","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"5254_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14740338.2017.1397128","volume":"17","author":"C Rong","year":"2018","unstructured":"Rong, C., Carmona, N. E., Lee, Y. L., Ragguett, R.-M., Pan, Z., Rosenblat, J. D., Subramaniapillai, M., Shekotikhina, M., Almatham, F., Alageel, A., Mansur, R., Ho, R. C., & McIntyire, R. S. (2018). Drug-drug interactions as a result of co-administering THC and CBD with other psychotropic agents. Expert Opinion on Drug Safety, 17(1), 51\u201354.","journal-title":"Expert Opinion on Drug Safety"},{"issue":"5","key":"5254_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","volume":"2","author":"JLR Rubenstein","year":"2003","unstructured":"Rubenstein, J. L. R., & Merzenich, M. M. (2003). Model of autism: Increased ratio of excitation\/inhibition in key neural systems. Genes, Brain and Behavior, 2(5), 255\u2013267.","journal-title":"Genes, Brain and Behavior"},{"issue":"1","key":"5254_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neuropharm.2007.06.024","volume":"54","author":"T Rubino","year":"2008","unstructured":"Rubino, T., Guidali, C., Vigano, D., Realini, N., Valenti, M., Massi, P., & Parolaro, D. (2008). CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology, 54(1), 151\u2013160.","journal-title":"Neuropharmacology"},{"issue":"1","key":"5254_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41598-018-37570-y","volume":"9","author":"LBL Schleider","year":"2019","unstructured":"Schleider, L. B. L., Mechoulam, R., Saban, N., Meiri, G., & Novack, V. (2019). Real life experience of medical cannabis treatment in autism: Analysis of safety and efficacy. Scientific Reports, 9(1), 200.","journal-title":"Scientific Reports"},{"key":"5254_CR29","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","volume":"391","author":"EA Thiele","year":"2018","unstructured":"Thiele, E. A., March, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., & GWPCARE4 Study Group. (2018). Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 391, 1085\u20131096.","journal-title":"Lancet"},{"issue":"23","key":"5254_CR30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219\u20132227.","journal-title":"New England Journal of Medicine"},{"key":"5254_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13181-016-0552-x","volume":"13","author":"GS Wang","year":"2017","unstructured":"Wang, G. S. (2017). Pediatric concerns due to expanded cannabis use: Unintended consequences of legalization. Journal of Medical Toxicology, 13, 99\u2013105.","journal-title":"Journal of Medical Toxicology"},{"issue":"9","key":"5254_CR32","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3390\/ijms18091916","volume":"18","author":"E Zamberletti","year":"2017","unstructured":"Zamberletti, E., Gabaglio, M., & Parolaro, D. (2017). The endocannabinoid system and autism spectrum disorders: Insights from animal models. International Journal of Molecular Sciences, 18(9), 1916.","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-021-05254-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-021-05254-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-021-05254-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T16:17:03Z","timestamp":1659543423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10803-021-05254-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5254"],"URL":"https:\/\/doi.org\/10.1007\/s10803-021-05254-8","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"type":"print","value":"0162-3257"},{"type":"electronic","value":"1573-3432"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"23 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}